16
Nov 3 (Reuters) – German pharmaceuticals and agriculture group Bayer (BAYGn.DE on Tuesday raised its 2026 profit outlook, citing a better-than-anticipated performance at the company’s pharmaceuticals business.
Reporting by Tristan Veyet in Gdansk, editing by Linda Pasquini
